Other Information.
−Removed: (c) During the quarter ended September 30, 2025,
−Removed: no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1
−Removed: trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
+Added: (c) During the quarter ended March 31, 2026, no
+Added: director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading
+Added: arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
The following exhibits are filed as part of, or
2 unchanged sentences
Amended and Restated Certificate of Incorporation of Apimeds Pharmaceuticals US, Inc.
−Removed: (incorporated herein by reference to Exhibit 3.1 to our Registration Statement on Form S-1 filed on September 25, 2024)
−Removed: Certificate of Amendment to the Amended and Restated Certificate of Incorporation (incorporated herein by reference to Exhibit 3.1 to our Annual Report on Form 10-K filed on April 15, 2025)
+Added: (incorporated by reference to our Schedule 14C filed on February 27, 2026).
+Added: Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Apimeds Pharmaceuticals US, Inc.
+Added: (incorporated by reference to our Schedule 14C filed on February 27, 2026).
Amended and Restated Bylaws of Apimeds Pharmaceuticals US, Inc.
(incorporated by reference to Exhibit 3.3 to our Annual Report on Form 10-K filed on April 15, 2025)
−Removed: First Amendment to Bylaws dated October 15, 2025 (incorporated by reference to Exhibit 3.1 to Form 8-K filed on October 16, 2025)
−Removed: Warrant Issued to Murdock Capital Partners Corp., dated August 5, 2025.
+Added: Amended and Restated Bylaws of Apimeds Pharmaceuticals US, Inc.
+Added: (incorporated by reference to our Schedule 14C filed on February 27, 2026).
+Added: Financial Advisory Agreement dated December 1, 2025.
Rule 13a-14(a) Certification by Principal Executive Officer
9 unchanged sentences
Cover Page Interactive Data File (formatted in iXBRL, and included in exhibit 101)
−Removed: Filed or furnished with this Quarterly Report.
+Added: or furnished with this Quarterly Report.
Pursuant to the requirements of the Securities
1 unchanged sentence
APIMEDS PHARMACEUTICALS US, INC.
−Removed: November 12, 2025
/s/ Erick Frim
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.